(S1 (S (S (NP (NP (NN Loss)) (PP (IN of) (NP (NN imprinting)))) (CC and) (VP (VBD elevated) (NP (NP (NN expression)) (PP (IN of) (NP (JJ wild-type) (NN p73))) (PP (IN in) (NP (JJ human) (JJ gastric) (NN adenocarcinoma)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN p73) (NN gene)) (ADJP (JJ located) (PP (IN at) (NP (CD 1p36.3))))) (VP (VBZ encodes) (PP (IN for) (NP (NP (DT a) (NN protein)) (PP (IN with) (NP (NP (JJ significant) (NN similarity)) (PP (TO to) (NP (NN p53))))))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NN penetrance)) (PP (IN of) (NP (NN p73))) (PP (IN in) (NP (JJ gastric) (NN carcinogenesis))))))) (, ,) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NP (NN expression)) (, ,) (NP (NN allelotype)) (, ,) (CC and) (NP (NN mutation))) (PP (IN of) (NP (NN p73))) (PP (IN in) (NP (NP (CD five) (NN cell) (NNS lines)) (CC and) (NP (CD 75) (NNS tissues)))))) (. .)))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (ADJP (RB extremely) (JJ low)) (NNS levels)) (PP (IN of) (NP (NN p73) (NN expression)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT all) (JJ noncancerous) (JJ gastric) (NNS tissues)) (CC and) (NP (QP (CD four) (IN of) (CD five)) (NN cell) (NNS lines)))))))) (, ,) (NP (NP (DT a) (JJ significant) (NN elevation)) (PP (IN of) (NP (NN p73)))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (QP (QP (CD 37) (IN of) (CD 39)) (PRN (-LRB- -LRB-) (NP (CD 94.9) (NN %)) (-RRB- -RRB-))) (NN carcinoma) (NNS tissues)))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT a) (JJ tumor-specific) (NN increase)) (PP (IN of) (NP (NN p73)))) (VP (VBD was) (VP (VBN identified) (PP (IN in) (NP (QP (QP (CD 14) (IN of) (CD 16)) (PRN (-LRB- -LRB-) (NP (CD 87.5) (NN %)) (-RRB- -RRB-))) (JJ matched) (NNS sets)))))) (. .)))
(S1 (S (NP (NP (NN Allelotyping) (NN analysis)) (VP (VBG using) (NP (NP (DT a) (NN StyI)) (CC or) (NP (NNP BanI) (NN polymorphism))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (QP (QP (CD 5) (IN of) (CD 21)) (PRN (-LRB- -LRB-) (NP (CD 23.8) (NN %)) (-RRB- -RRB-))) (JJ informative) (NNS carcinomas)) (, ,) (CC but) (NP (NP (NN none)) (PP (IN of) (NP (CD 19) (JJ noncancerous) (NNS cases)))) (, ,)) (VP (VBP express) (NP (NN p73)) (ADVP (RB biallelically)) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT a) (JJ silent) (NN allele))) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NNS cancers)))))))))))) (. .)))
(S1 (S (S (SBAR (IN Whereas) (S (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (DT an) (JJ active) (NN allele)))) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NN serum) (NN starvation)) (CC or) (NP (NN clump) (NN formation))) (PP (IN of) (NP (DT the) (NNS cells))))))))) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NN 5-aza-2'deoxycytidine)))) (VP (VBD activated) (NP (DT a) (JJ silent) (NN allele)) (PP (IN with) (NP (NP (DT a) (JJ subsequent) (NN up-regulation)) (PP (IN of) (NP (DT an) (JJ active) (NN allele))))) (, ,) (S (VP (VBG supporting) (NP (NP (DT the) (JJ genomic) (NN imprinting)) (CC and) (NP (NP (NN autoregulation)) (PP (IN of) (NP (DT the) (NN gene))))))))) (. .)))
(S1 (S (S (S (NP (NP (NP (JJ Allelic) (NN deletion)) (CC or) (NP (NN mutation))) (PP (IN of) (NP (DT the) (NN gene)))) (VP (VBD was) (RB not) (VP (VBN found)))) (, ,) (CC and) (S (NP (NP (DT no) (NN association)) (PP (IN of) (NP (NN p73) (NN expression))) (PP (IN with) (NP (NP (DT the) (JJ mutational) (NN status)) (PP (IN of) (NP (NP (NN p53)) (CC or) (NP (NP (NN expression)) (PP (IN of) (NP (NN p21Waf1))))))))) (VP (VBD was) (VP (VBN recognized))))) (. .)))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT this) (NN study)) (VP (VBZ argues) (SBAR (IN that) (S (NP (NN p73)) (VP (VP (VBZ is) (RB not) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (NP (JJ genetic) (NN alteration)) (PP (IN in) (NP (JJ gastric) (NN carcinogenesis))))))) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (NN p73)))) (VP (MD might) (VP (VB be) (VP (VBN triggered) (PP (IN by) (NP (NP (JJ physiological) (NNS stresses)) (VP (VBN accompanied) (PP (IN with) (NP (NP (NN outgrowth)) (PP (IN of) (NP (NNS tumors)))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN hypoxia)) (CC or) (NP (JJ nutrient) (NN deprivation))))))))))))))))) (. .)))
